Adamas Pharmaceuticals Inc. buy Quitte
Start price
23.12.15
/
50%
€20.62
Target price
06.01.16
€23.36
Performance (%)
12.12%
End price
06.01.16
€23.12
Summary
This prediction ended on 06.01.16 with a price of €23.12. The BUY prediction by Quitte finished with a performance of 12.12%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by Quitte for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
Erfolge bei Parkinson
Adamas Pharma: Phase-3-Studie zu ADS-5102 erzielt gewünschte Resultate
(Stop Loss Kurs erreicht)

